Skip to content
This GLP
By This GLP Editorial Team · Updated October 2026AI intake, clinician decisions

Medivive review

Medivive starts with an AI conversation, then assigns prescribing decisions to TrueEval Medical Group. The weight program describes 30-day monitoring.

The verdict

A named clinical group and a stated monitoring interval make the model easier to examine. The AI and biomarker claims should not substitute for checking who reviews your case, what testing is required and how to reach a clinician.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Prescription
Required
Compounded
Yes — not FDA-approved

Medivive offers bilingual virtual care across weight management, hormones and other services. Its weight program names compounded semaglutide and tirzepatide.

  1. Who writes the prescription, and what do they see?

    The site identifies TrueEval Medical Group and says a clinician licensed in the patient’s state reviews the case. The assistant proposes candidate protocols but does not independently prescribe.

    The initial conversation gathers goals and history before a provider reviews the proposed treatment. Medivive also markets at-home blood collection and wearable data; confirm which of those services your weight plan actually includes.

  2. What happens when the dose goes up?

    The weight page specifies provider check-ins every 30 days for tolerability and progress, with individualized dose adjustment. Ask how to report symptoms that cannot wait for the scheduled review.

  3. What the price includes

    The public pages describe self-pay treatment without a membership fee. The exact price appears after protocol matching; a public, dose-specific recurring total was not established.

  4. What it claims, and what it cites

    The weight page explicitly identifies compounded semaglutide and tirzepatide from a 503A pharmacy. These products are not FDA-approved, and a sophisticated intake system does not change that status.

Where it holds up, and where it does not

  • Strength: Named medical group
  • Strength: Thirty-day weight-care monitoring
  • Limitation: AI performance claims are not outcome evidence
  • Limitation: Exact price appears after matching

What the evidence says about this kind of treatment

The assessment above is about Medivive. These are about the drugs it sells, and they are traced to the primary literature.

Right for
Someone comfortable with an AI-assisted intake who wants a clinician to retain prescribing authority.
Wrong for
Someone seeking a human-only intake or a complete published price table before assessment.

The evidence behind what Medivive prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How Medivive compares

SellerWho it suitsGo
SkinnyRxReaders choosing tirzepatide, the one line with a published standing rateSee SkinnyRx →
ShedRxReaders willing to telephone a seller and ask which published fee is the real oneSee ShedRx →
RxSpan MDBuyers who want the standing rate, the pharmacy and the prescriber named before signing upSee RxSpan MD →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: BeyondMDBig Easy Weight LossBiltRxBionomy HealthBioverseBlis MD

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Can the AI prescribe?
Medivive says no: a licensed clinician reviews the case and can revise the proposed protocol.
Is bloodwork always included?
The platform advertises extensive testing, but patients should confirm the requirement and included costs for their specific weight program.

Sources for this review

Provider information checked . Terms can change.

This GLP Editorial TeamPublisher · Updated October 2026

How this was assessed. The four questions above are answered from Medivive’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.